These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2543535

  • 1. Kinetics and dynamics of enalapril in patients with liver cirrhosis.
    Ohnishi A, Tsuboi Y, Ishizaki T, Kubota K, Ohno T, Yoshida H, Kanezaki A, Tanaka T.
    Clin Pharmacol Ther; 1989 Jun; 45(6):657-65. PubMed ID: 2543535
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses.
    Gardner SY, Atkins CE, Sams RA, Schwabenton AB, Papich MG.
    J Vet Intern Med; 2004 Jun; 18(2):231-7. PubMed ID: 15058776
    [Abstract] [Full Text] [Related]

  • 3. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of enalapril in normal volunteers.
    Ishizaki T, Baba T, Murabayashi S, Kubota K, Hara K, Kurimoto F.
    J Cardiovasc Pharmacol; 1988 Jun; 12(5):512-9. PubMed ID: 2468049
    [Abstract] [Full Text] [Related]

  • 4. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Ajayi AA, Hockings N, Reid JL.
    Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach.
    Ribeiro W, Muscará MN, Martins AR, Moreno H, Mendes GB, de Nucci G.
    Eur J Clin Pharmacol; 1996 Apr; 50(5):399-405. PubMed ID: 8839663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
    Baba T, Murabayashi S, Tomiyama T, Takebe K.
    Br J Clin Pharmacol; 1990 Jun; 29(6):766-9. PubMed ID: 2165799
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays.
    Arafat T, Awad R, Hamad M, Azzam R, Al-Nasan A, Jehanli A, Matalka K.
    J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects.
    Weisser K, Schloos J, Lehmann K, Düsing R, Vetter H, Mutschler E.
    Eur J Clin Pharmacol; 1991 Aug; 40(1):95-9. PubMed ID: 1647954
    [Abstract] [Full Text] [Related]

  • 13. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP, Lal SM, Whalen JJ, Bauer JH.
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.